13,000 Shares in Innospec Inc. (NASDAQ:IOSP) Acquired by Healthcare of Ontario Pension Plan Trust Fund

Healthcare of Ontario Pension Plan Trust Fund acquired a new position in shares of Innospec Inc. (NASDAQ:IOSP - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 13,000 shares of the specialty chemicals company's stock, valued at approximately $1,470,000. Healthcare of Ontario Pension Plan Trust Fund owned 0.05% of Innospec at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Quantbot Technologies LP purchased a new position in Innospec during the 3rd quarter worth approximately $1,294,000. Algert Global LLC raised its holdings in shares of Innospec by 15.3% during the third quarter. Algert Global LLC now owns 51,512 shares of the specialty chemicals company's stock worth $5,825,000 after purchasing an additional 6,840 shares during the last quarter. Cerity Partners LLC lifted its position in Innospec by 324.5% during the third quarter. Cerity Partners LLC now owns 13,664 shares of the specialty chemicals company's stock valued at $1,545,000 after purchasing an additional 10,445 shares during the period. Citigroup Inc. boosted its holdings in Innospec by 46.1% in the third quarter. Citigroup Inc. now owns 32,193 shares of the specialty chemicals company's stock valued at $3,641,000 after purchasing an additional 10,162 shares during the last quarter. Finally, Raymond James Trust N.A. grew its position in Innospec by 7.9% during the 3rd quarter. Raymond James Trust N.A. now owns 2,106 shares of the specialty chemicals company's stock worth $238,000 after purchasing an additional 155 shares during the period. 96.64% of the stock is currently owned by institutional investors and hedge funds.

Innospec Stock Up 1.5 %

Shares of NASDAQ:IOSP traded up $1.79 during trading on Monday, hitting $120.40. 80,751 shares of the stock traded hands, compared to its average volume of 109,381. The company has a fifty day moving average price of $114.50 and a two-hundred day moving average price of $118.22. Innospec Inc. has a 52-week low of $103.97 and a 52-week high of $133.71. The company has a market cap of $3.00 billion, a price-to-earnings ratio of 20.83 and a beta of 1.08.

Innospec (NASDAQ:IOSP - Get Free Report) last issued its quarterly earnings data on Tuesday, November 5th. The specialty chemicals company reported $1.35 earnings per share for the quarter, hitting analysts' consensus estimates of $1.35. Innospec had a net margin of 7.68% and a return on equity of 13.33%. The business had revenue of $443.40 million during the quarter, compared to the consensus estimate of $442.13 million. During the same quarter in the prior year, the firm posted $1.59 earnings per share. The company's revenue was down 4.5% compared to the same quarter last year. On average, equities research analysts predict that Innospec Inc. will post 5.88 EPS for the current fiscal year.

Innospec Increases Dividend

The firm also recently disclosed a Semi-Annual dividend, which was paid on Tuesday, November 26th. Shareholders of record on Monday, November 18th were issued a $0.79 dividend. This is a positive change from Innospec's previous Semi-Annual dividend of $0.72. This represents a yield of 1.3%. The ex-dividend date of this dividend was Monday, November 18th. Innospec's dividend payout ratio (DPR) is presently 27.57%.

Insider Activity

In other news, Director Milton C. Blackmore sold 1,035 shares of Innospec stock in a transaction dated Wednesday, November 13th. The shares were sold at an average price of $122.92, for a total value of $127,222.20. Following the sale, the director now owns 9,028 shares in the company, valued at $1,109,721.76. This trade represents a 10.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.52% of the company's stock.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded Innospec from a "strong-buy" rating to a "buy" rating in a research note on Thursday, August 8th.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.